Form4insider filings, from the source

SEC Form 4 · accession 0001140361-15-044057

Relypsa Inc · RLYP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Lance Berman
Officer — Chief Medical Officer and SVP
Period of report
Dec 7, 2015
Accepted (ET)
Dec 9, 2015 · 8:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001416792

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Dec 7, 2015M13,896$3.96A35,186D
Common StockF1Dec 7, 2015M11,349$3.96A46,535D
Common StockF1Dec 7, 2015M4,755$7.40A51,290D
Common StockF1Dec 7, 2015S30,000$29.78D21,290D
Common StockF1Dec 9, 2015M750$7.40A22,040D
Common StockF1Dec 9, 2015S750$29.50D21,290D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F3$3.96Dec 7, 2015M13,896D—Dec 13, 2021Common Stock13,89610,668D
Stock Option (right to buy)F4$3.96Dec 7, 2015M11,349D—Sep 27, 2022Common Stock11,34921,765D
Stock Option (right to buy)F5$7.40Dec 7, 2015M4,755D—Jul 23, 2023Common Stock4,75526,164D
Stock Option (right to buy)F5$7.40Dec 9, 2015M750D—Jul 23, 2023Common Stock75025,414D

Explanation of responses